Part 1
Honoured to be presenting iROC trial results comparing iRARC vs ORC for Bladder cancer at #AUA22
RARC provides patients MORE days alive and out of hospital at 90 days vs ORC (82 vs 80 days)
Full paper in JAMA now https://t.co/rGl1pCGw98
What a weekend! ⚽️
Also… huge honour to lead my first Focal One Robotic HIFU list!
@ImperialNHS@IP_London
Indebted to:
@LondonProstate1@TaimurShah@FocalOneHIFU@joshuarobotics
Dr Pierre Charles Henry (HIFU Proctor)
Dr Markovic (Anaesthetist)
Anmol & Alfin
Onwards & upwards. Delighted to add this fantastic focal therapy option to the armamentarium. Excellent user interface & image integration.
#HIFU #FocalTherapy #July4th #QuaterFinals
We have a fully funded 3 yr PhD post @ucl, deadline 12th Nov. Research is on optimising prostate cancer diagnosis using imaging (e.g MRI, PET, AI). Join our world-class team with proven track-record 4 changing practice. https://t.co/tlNQBaqxu9 @BURSTurology@BSUroRad@ESRUrology
1/n 🔥HOT OFF THE PRESS🔥
#PRIME Trial just published @JAMA_current
⭐Level 1 evidence that biparametric MRI (- contrast) is non-inferior to multiparametric #MRI (+ contrast) for #prostatecancer detection
⏱️ for a new standard of care
🔗https://t.co/2E6pBrCf1y
#UroSoMe
Congratulations @shailes79692225 for your nomination for the silver cystoscope award!! A reflection of your dedication and hard work as a trainer and as the NCEL Training programme director. Well deserved!!
We have a fully funded 3 year PhD post @ucl starting Aug 2025. Research is on optimising prostate cancer diagnosis using imaging (e.g MRI, PET, AI). Join our world-class team with proven track-record for changing practice. DM me if interested @BURSTurology@BSUroRad@ESRUrology
I would strongly encourage anyone with a passion for MedEd to apply! Being able to support applicants in their Urology ST3 Interviews through courses etc. have been one of the most rewarding things I have done. We also have very exciting projects underway! @BSoT_UK
🚨Neurosafe RCT(n=407) at gamechanger sess by Greg Shaw #EAU25. In men with good baseline erections having RALP, 12 mth erectile function better with neurosafe technique vs SOC (IIEF 12.7vs9.7, p<0.001) & early continence better. Published @TheLancetOncol https://t.co/gCfwIhCs1N
🚨 Calling all Urology consultants! 🚨
Offer a urology fellowship? 🎓 Add it to the BAUS Fellowship Directory to help trainees find you!
🔗 https://t.co/HnSreYfzPA
If you prefer filling up a PDF Version, get in touch!
Questions? DM me!
#Urology#Fellowship#BAUS
Had a great time at my 6th AUA meeting presenting my research, attending some excellent talks, catching up with friends and eating my weight in brisket. #AUA24
ASiT and the Surgical Specialty Training Organisations have released a joint statement in response to a recently published in The Annals of the Royal College of Surgeons England
What should be the #priorities in delivering surgical care?
Share with us your thoughts
🔗 https://t.co/ZmmfWbQy0s
Nice summary of data of existing and future BCG unresponsive NMIBC treatment by @MarkTysonMD . Local bladder treatment is the way to go rather than systemic therapy to reduce tox. #AUA2024.
Some challenges to the #EAUGuidelines? ✍️ The latest results on the PRIME study, PROBASE trial & ProScreen featured during the #ProstateCancer Game changing session at #EAU24 today.
Read the report here to learn more about the results 👇
https://t.co/LQkfw7IWY2
🚨 Breaking results 🚨 @PrimeMRI study presented at #EAU24@Uroweb. This 🌍 multicentre trial (n=555, 22 sites) showed that biparametric MRI without contrast is non-inferior 2 multiparametric MRI & should be the new standard for prostate cancer diagnosis if image quality is good
3️⃣ days until PRIME 🏃🏻♀️💨💨
There are now only ✨3️⃣✨ days left until the PRIME preliminary outcome data will be presented at #EAU24‼️
🔔 Remember:
🗓️ Saturday 6th April
🕰️ 9:55am - 10:08am
📍 Game-changing Plenary
#UroSoMe#prostatecancer#prostateMRI#PRIMEEAU24
Clinical outcomes after robot-assisted radical cystectomy vs open radical. #ExpertCommentary with @FaltasLab@WCMEnglanderIPM discussing a study by @p_khetrapal et al. performed a systematic review and meta-analysis of randomized controlled trials > https://t.co/sPHHOCeHhg
✨ The #PRIME team met up over some pad thai 🍽️ and green curry 🍛 recently to celebrate how far PRIME has come over these past few years 🏃🏻♀️ and to eagerly anticipate for the presentation of our preliminary trial results at #EAU24 ! 💯🥅
#UroSoMe#prostatecancer#prostateMRI
📣 ANNOUNCEMENT 📣
Check out our last post ➡️ @veerukasi will be presenting PRIME’s ✨ preliminary primary outcome data ✨ at #EAU24 this year ‼️
🗓️ Saturday 6th April
🕰️ 9:55-10:08
This is not one to miss! 🚀
#UroSoMe#prostatecancer#prostateMRI#PRIMEEAU24